Europe Peptide Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type (Generic, Innovative); Route of Administration (Parenteral, Oral, Mucosal, Pulmonary, Others); Synthesis Technology (Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), Hybrid Technology); Application (Cancer, Cardiovascular Disorder, Metabolic Disorder, Respiratory Disorder, Pain, Dermatology), and Country
Market Introduction
A patient portal is an online application that enables the maintenance of the data of patients. The patient portal is a web-based solution connected with electronic health records and allows patients to access their health records. The patients can share their health information and communicate remotely.
Get more information on this report :
Market Overview and Dynamics
The Europe peptide therapeutics market is expected to reach US$ 13,845.87 million by 2027 from US$ 6,988.39 million in 2019; it is estimated to grow at a CAGR of 9.0% from 2020 to 2027. The growth of the Europe peptide therapeutics market is attributed to key driving factors, such as growing investments in peptide therapeutics and increasing prevalence of metabolic disorders and infectious diseases. However, operational limitations of peptides are expected to restrain the growth of the market during the forecast period.
Key Market Segments
Based on type, the Europe peptide therapeutics market is segmented into generic and innovative. The innovative segment held the largest share of the market in 2019, whereas the generic segment is anticipated to register the highest CAGR in the market during the forecast period.
In terms of route of administration, the Europe peptide therapeutics market is categorized into parenteral, oral, mucosal, pulmonary, and others. The parenteral segment held the largest share of the market in 2019; however, the oral segment is anticipated to register the highest CAGR in the market during the forecast period.
Based on synthesis technology, the Europe peptide therapeutics market is segmented into solid phase peptide synthesis (SPPS), liquid phase peptide synthesis (LPPS), and hybrid technology. The solid phase peptide synthesis segment held the largest share of the market in 2019. The hybrid technology segment is anticipated to register the highest CAGR in the market during the forecast period.
Based on application, the Europe peptide therapeutics market is categorized into cancer, cardiovascular disorder, metabolic disorder, respiratory disorder, pain, and dermatology. The cancer segment held the largest share of the market in 2019. However, the metabolic disorder segment is estimated to register the highest CAGR in the market during the forecast period.
Major Sources and Companies Listed
A Few of the primary and secondary sources associated with this report on the Europe peptide therapeutics market are the Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFIG), Cancer Research UK (CRUK) and International Agency for Research on Cancer (IARC).
Reasons to buy the report
- Determine prospective investment areas based on a detailed trend analysis of the Europe peptide therapeutics market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the Europe peptide therapeutics market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Europe peptide therapeutics market.
EUROPE PEPTIDE THERAPEUTICS SEGMENTATION
- Innovative
- Generic
- Parenteral
- Mucosal
- Oral
- Pulmonary
- Others
- Solid Phase Peptide Synthesis (SPPS)
- Liquid Phase Peptide Synthesis (LPPS)
- Hybrid Technology
- Cancer
- Metabolic Disorder
- Cardiovascular Disorder
- Respiratory Disorder
- Pain
- Dermatology
By Country
- Gemany
- Italy
- France
- United kingdom
- Spain
- Rest of Europe
Company Profiles
- Amgen Inc.
- Eli Lilly and Company
- EVER Pharma GmbH
- Polypeptide Group
- TEVA PHARMACEUTICAL INDUSTRIES LTD
- AstraZeneca
- Bristol-Myers Squibb Company
- GlaxoSmithKline plc
- Novo Nordisk A/S
- Sanofi
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Peptide Therapeutics Market – By Type
1.3.2 Europe Peptide Therapeutics Market – By Route of Administration
1.3.3 Europe Peptide Therapeutics Market – By Synthesis Technology
1.3.4 Europe Peptide Therapeutics Market – By Application
1.3.5 Europe Peptide Therapeutics Market – By Country
2. Peptide Therapeutics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Peptide Therapeutics – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe – PEST Analysis
4.3 Expert Opinion
5. Peptide Therapeutics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Investments on Peptide Therapeutics
5.1.2 Increasing Prevalence of Metabolic Disorders and Infectious Diseases
5.2 Market Restraints
5.2.1 Operational Limitations of Peptides
5.3 Market Opportunities
5.3.1 Strong Pipeline and Applications of Peptide Drugs
5.4 Future Trends
5.4.1 Emphasis on Automatic Peptide Synthesis
5.5 Impact Analysis
6. Peptide Therapeutics Market – Europe Analysis
6.1 Europe Peptide Therapeutics Market Revenue Forecast and Analysis
7. Peptide Therapeutics Market Analysis – By Type
7.1 Overview
7.2 Peptide Therapeutics Market Revenue Share, by Type (2019 and 2027)
7.3 Generic
7.3.1 Overview
7.3.2 Generic: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Innovative
7.4.1 Overview
7.4.2 Innovative: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
8. Peptide Therapeutics Market Analysis – By Route of Administration
8.1 Overview
8.2 Peptide Therapeutics Market Revenue Share, by Route of Administration (2019 and 2027)
8.3 Parenteral
8.3.1 Overview
8.3.2 Parenteral: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Oral
8.4.1 Overview
8.4.2 Oral: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Mucosal
8.5.1 Overview
8.5.2 Mucosal: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Pulmonary
8.6.1 Overview
8.6.2 Pulmonary: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
9. Peptide Therapeutics Market Analysis – By Synthesis Technology
9.1 Overview
9.2 Peptide Therapeutics Market Revenue Share, by Synthesis Technology (2019 and 2027)
9.3 Solid Phase Peptide Synthesis (SPPS)
9.3.1 Overview
9.3.2 Solid Phase Peptide Synthesis (SPPS): Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Liquid Phase Peptide Synthesis (LPPS)
9.4.1 Overview
9.4.2 Liquid Phase Peptide Synthesis (LPPS): Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Hybrid Technology
9.5.1 Overview
9.5.2 Hybrid Technology: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
10. Peptide Therapeutics Market– Application
10.1 Overview
10.2 Peptide Therapeutics Market Share, Application, 2019 and 2027 (%)
10.3 Cancer
10.3.1 Overview
10.3.2 Cancer: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)
10.4 Cardiovascular Disorders
10.4.1 Overview
10.4.2 Cardiovascular Disorders: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)
10.5 Metabolic Disorder
10.5.1 Overview
10.5.2 Metabolic Disorder: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)
10.6 Respiratory Disorders
10.6.1 Overview
10.6.2 Respiratory Disorders: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)
10.7 Pain
10.7.1 Overview
10.7.2 Pain: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)
10.8 Dermatology
10.8.1 Overview
10.8.2 Dermatology: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)
11. Peptide Therapeutics Market – Europe Analysis
11.1 Europe: Peptide Therapeutics Market
11.1.1 Overview
11.1.2 Europe: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.3 Europe: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)
11.1.4 Europe: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)
11.1.5 Europe: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)
11.1.6 Europe: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)
11.1.7 Europe: Peptide Therapeutics Market, by Country, 2019& 2027 (%)
11.1.8 Germany: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.8.1 Germany: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.8.2 Germany: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)
11.1.8.3 Germany: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)
11.1.8.4 Germany: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)
11.1.8.5 Germany: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)
11.1.9 UK: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.9.1 UK: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.9.2 UK: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)
11.1.9.3 UK: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)
11.1.9.4 UK: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)
11.1.9.5 UK: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)
11.1.10 France: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.10.1 France: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.10.2 France: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)
11.1.10.3 France: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)
11.1.10.4 France: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)
11.1.10.5 France: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)
11.1.11 Spain: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.11.1 Spain: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.11.2 Spain: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)
11.1.11.3 Spain: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)
11.1.11.4 Spain: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)
11.1.11.5 Spain: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)
11.1.12 Italy: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.12.1 Italy: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.12.2 Italy: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)
11.1.12.3 Italy: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)
11.1.12.4 Italy: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)
11.1.12.5 Italy: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)
11.1.13 Rest of Europe: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.13.1 Rest of Europe: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.13.2 Rest of Europe: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)
11.1.13.3 Rest of Europe: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)
11.1.13.4 Rest of Europe: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)
11.1.13.5 Rest of Europe: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)
12. Impact of COVID-19 Pandemic on Europe Peptide Therapeutics Market
12.1 Europe: Impact Assessment of COVID-19 Pandemic
12.2 Inorganic Developments
12.2.1 Overview
13. Company Profiles
13.1 Amgen Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Eli Lilly and Company
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 EVER Pharma GmbH
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Polypeptide Group
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 TEVA PHARMACEUTICAL INDUSTRIES LTD
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 AstraZeneca
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Bristol-Myers Squibb Company
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 GlaxoSmithKline plc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Novo Nordisk A/S
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Sanofi
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 2. Europe Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 3. Europe Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)
Table 4. Europe Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 5. Germany Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 6. Germany Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 7. Germany Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)
Table 8. Germany Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 9. UK Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 10. UK Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 11. UK Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)
Table 12. UK Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 13. France Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 14. France Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 15. France Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)
Table 16. France Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 17. Spain Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 18. Spain Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 19. Spain Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)
Table 20. Spain Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 21. Italy Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 22. Italy Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 23. Italy Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)
Table 24. Italy Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 25. Rest of Europe Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 26. Rest of Europe Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 27. Rest of Europe Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)
Table 28. Rest of Europe Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 29. Organic Developments Done by Companies
Table 30. Inorganic Developments Done by Companies
Table 31. Glossary of Terms, Peptide Therapeutics Market
LIST OF FIGURES
Figure 1. Peptide Therapeutics Market Segmentation
Figure 2. Peptide Therapeutics Market Segmentation, By Country
Figure 3. Europe Peptide Therapeutics Market Overview
Figure 4. Innovative Segment Held Largest Share of Peptide Therapeutics Market
Figure 5. Europe Peptide Therapeutics Market – Leading Country Markets (US$ Million)
Figure 6. Europe PEST Analysis
Figure 7. Peptide Therapeutics Market Impact Analysis of Drivers and Restraints
Figure 8. Europe Peptide Therapeutics Market – Revenue Forecast and Analysis – 2019- 2027
Figure 9. Peptide Therapeutics Market Revenue Share, by Type (2019 and 2027)
Figure 10. Generic: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 11. Innovative: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Peptide Therapeutics Market Revenue Share, by Route of Administration (2019 and 2027)
Figure 13. Parenteral: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Oral: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Mucosal: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Pulmonary: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Others: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Peptide Therapeutics Market Revenue Share, by Synthesis Technology (2019 and 2027)
Figure 19. Solid Phase Peptide Synthesis (SPPS): Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Liquid Phase Peptide Synthesis (LPPS): Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Hybrid Technology: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Peptide Therapeutics Market Share, Application, 2019 and 2027 (%)
Figure 23. Cancer: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)
Figure 24. Cardiovascular Disorders: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)
Figure 25. Metabolic Disorder: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)
Figure 26. Respiratory Disorders: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)
Figure 27. Pain: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)
Figure 28. Dermatology: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)
Figure 29. Europe: Peptide Therapeutics Market, by Key Country – Revenue (2019) (USD Million)
Figure 30. Europe Peptide Therapeutics Market Revenue and Forecast to 2027 (USD Million)
Figure 31. Europe: Peptide Therapeutics Market, by Country, 2019& 2027 (%)
Figure 32. Germany: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
Figure 33. UK: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
Figure 34. France: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
Figure 35. Spain: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
Figure 36. Italy: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
Figure 37. Rest of Europe: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
Figure 38. Impact of COVID-19 Pandemic in European Country Markets
- Amgen Inc.
- Eli Lilly and Company
- EVER Pharma GmbH
- Polypeptide Group
- TEVA PHARMACEUTICAL INDUSTRIES LTD
- AstraZeneca
- Bristol-Myers Squibb Company
- GlaxoSmithKline plc
- Novo Nordisk A/S
- Sanofi
- Determine prospective investment areas based on a detailed trend analysis of the Europe peptide therapeutics market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the Europe peptide therapeutics market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Europe peptide therapeutics market.